Biotechnological companies using AI
Lunai Bioworks (NASDAQ: LNAI), an AI--driven biotechnology company, announced the issuance of U.S. Patent No. 12,369,861 for "Methods, Systems, and Frameworks for Debiasing Data in Drug Discovery Predictions." This patent protects their multimodal data standardization and structural bias--removal layer, which is utilized before AI predictive modeling across CNS, oncology, and biodefense programs. The news led to a 14.1% surge in the company's stock.